|
⚲
|
| Keyboard |
| Timothy Mayleben | |
|---|---|
| Firm | |
| Address | c/o Lycera Corp 2800 Plymouth Rd, Ncrc, Building 26 Ann Arbor, MI 48109 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Lycera Corp | 021-242213 | Director | 29.9 M | ||
| Denovo Sciences Inc | 021-226851 | Director | 2.2 M of 2.2 M |
||
| Lycera Corp | 021-214958 | Director | 4.0 M of 9.2 M |
||
| Lycera Corp | 021-204965 | Director | 5.0 M of 5.7 M |
||
| Marinus Pharmaceuticals Inc | 021-188532 | Director | 21.8 M of 22.3 M |
||
| Aastrom Biosciences Inc | 021-175515 | Executive Officer | 40.0 M of 40.0 M |
||
| Esperion Therapeutics Inc | 021-118048 | Director | 27.9 M of 38.8 M |
||
| Marinus Pharmaceuticals Inc | 021-59654 | Director | 20.4 M | ||
| Lycera Corp | 021-96985 | Director | 33.9 M of 38.9 M |
||